Industry
Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma
Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised 400 million in new funding, nearly trip
Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised 400 million in new funding, nearly tripling its valuation to 3.8 billion. Index Ventures led the Series C round alongside Kleiner Perkins, Sequoia Capital and Dimension. New investors joining the investment included Bain Capital […] The post Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma appeared first on SiliconANGLE.
Related
Source: SiliconANGLE | 2026-07-14